| 标题 |
Disitamab vedotin with or without PD-1 inhibitors in pretreated patients with locally advanced or metastatic urothelial carcinoma: Identifying patients who derive additional benefit from immune combination therapy |
| 网址 | |
| DOI | |
| 其它 |
期刊:Urologic Oncology-seminars and Original Investigations 作者:Mengnan Qu; J. B. Wei; Jiazhi Mo; Jiayuan Chen; Xiaowen Wu; et al 出版日期:2025-12-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)